Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a type of blood cancer called peripheral T-cell lymphoma that has come back or stopped responding to at least one round of treatment
- People who are 18 years of age or older
- People whose general health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scoring system (confirm with trial site)
- People who have at least one tumour that is large enough to be measured on a CT or MRI scan, meeting specific size requirements
- People whose blood counts, heart function, kidney function, and liver function all meet minimum levels set by the trial (confirm with trial site for exact values)
- Women who could become pregnant must have a negative pregnancy test before joining, and all participants must agree to use effective contraception during the treatment period and for one year afterwards
- People with a life expectancy of more than 3 months
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who have had major surgery or a serious physical injury within 2 weeks before enrolment, or who have not yet recovered from its effects
- People who have had another type of cancer within the past 3 years, except for certain types of skin cancer, early-stage bladder cancer, or early-stage cervical or prostate conditions that have been fully treated and cured
- People who have had a stroke or bleeding in the brain within the past 3 months
- People with serious heart conditions (such as heart failure, a recent heart attack within 6 months, or unstable heart rhythm or chest pain) or serious lung conditions (such as severe breathing problems or a history of significant bronchospasm)
- People with HIV infection, or hepatitis B or hepatitis C that is currently active and not under control
- People with an active infection that cannot be controlled
- People who are currently pregnant or breastfeeding
- People with any other life-threatening illness or organ problem that the medical team considers too great a risk for participation
- People whose body may not be able to properly absorb or process the study medications (confirm with trial site)
- People whose lymphoma has spread to the brain or spinal cord
- People with any other condition that the trial doctor believes would make safe or full participation difficult, or that could affect how the trial results are interpreted
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-512-67781831
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR) after 6 treatment cycles
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.